Back to trial details

Intake questionnaire

Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)

Applying to The University of Texas MD Anderson Cancer Center · Houston, Texas

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with HER2-negative Breast Cancer?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Houston for study visits?